These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1803412)

  • 1. Antigenic analysis of Rift Valley fever virus isolates: monoclonal antibodies distinguish between wild-type and neurotropic virus strains.
    Besselaar TG; Blackburn NK; Meenehan GM
    Res Virol; 1991; 142(6):469-74. PubMed ID: 1803412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topological mapping of antigenic sites on the Rift Valley fever virus envelope glycoproteins using monoclonal antibodies.
    Besselaar TG; Blackburn NK
    Arch Virol; 1991; 121(1-4):111-24. PubMed ID: 1722089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pathogenicity and antigenic cross-reactivity of Rift Valley fever and other African phleboviruses in sheep.
    Swanepoel R; Struthers JK; Erasmus MJ; Shepherd SP; McGillivray GM; Shepherd AJ; Hummitzsch DE; Erasmus BJ; Barnard BJ
    J Hyg (Lond); 1986 Oct; 97(2):331-46. PubMed ID: 3537119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of monoclonal antibodies to Rift Valley Fever Virus and their application in antigen detection and indirect immunofluorescence.
    Mroz C; Schmidt KM; Reiche S; Groschup MH; Eiden M
    J Immunol Methods; 2018 Sep; 460():36-44. PubMed ID: 29894749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and application of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein NP and glycoproteins Gn and Gc.
    Jäckel S; Eiden M; Dauber M; Balkema-Buschmann A; Brun A; Groschup MH
    Arch Virol; 2014 Mar; 159(3):535-46. PubMed ID: 24100475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of a Recombinant Nucleocapsid Protein of Rift Valley Fever Virus in Vero Cells as an Immunofluorescence Antigen and Its Use for Serosurveillance in Traditional Cattle Herds in Zambia.
    Saasa N; Kajihara M; Dautu G; Mori-Kajihara A; Fukushi S; Sinkala Y; Morikawa S; Mweene A; Takada A; Yoshimatsu K; Arikawa J
    Vector Borne Zoonotic Dis; 2018 May; 18(5):273-277. PubMed ID: 29652643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.
    Ikegami T; Hill TE; Smith JK; Zhang L; Juelich TL; Gong B; Slack OA; Ly HJ; Lokugamage N; Freiberg AN
    J Virol; 2015 Jul; 89(14):7262-76. PubMed ID: 25948740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of a recombinant Rift Valley fever virus N protein for the detection of IgG and IgM antibodies in humans and animals by indirect ELISA.
    Jansen van Vuren P; Potgieter AC; Paweska JT; van Dijk AA
    J Virol Methods; 2007 Mar; 140(1-2):106-14. PubMed ID: 17174410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
    Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic and biological properties of Rift Valley fever virus isolated during the 1987 Mauritanian epidemic.
    Saluzzo JF; Anderson GW; Hodgson LA; Digoutte JP; Smith JF
    Res Virol; 1989; 140(2):155-64. PubMed ID: 2474189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rift valley Fever in Kruger national park: do buffalo play a role in the inter-epidemic circulation of virus?
    Beechler BR; Bengis R; Swanepoel R; Paweska JT; Kemp A; van Vuren PJ; Joubert J; Ezenwa VO; Jolles AE
    Transbound Emerg Dis; 2015 Feb; 62(1):24-32. PubMed ID: 24330522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
    Terasaki K; Tercero BR; Makino S
    Virus Res; 2016 May; 216():55-65. PubMed ID: 26022573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and antigenic relationship between Rift Valley fever virus strains isolated in Egypt and Madagascar.
    Saluzzo JF; Anderson GW; Smith JF; Fontenille D; Coulanges P
    Trans R Soc Trop Med Hyg; 1989; 83(5):701. PubMed ID: 2617635
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of bacterial expression cloning to define the amino acid sequences of antigenic determinants on the G2 glycoprotein of Rift Valley fever virus.
    Keegan K; Collett MS
    J Virol; 1986 May; 58(2):263-70. PubMed ID: 2422392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralization mechanism of human monoclonal antibodies against Rift Valley fever virus.
    Wang Q; Ma T; Wu Y; Chen Z; Zeng H; Tong Z; Gao F; Qi J; Zhao Z; Chai Y; Yang H; Wong G; Bi Y; Wu L; Shi R; Yang M; Song J; Jiang H; An Z; Wang J; Yilma TD; Shi Y; Liu WJ; Liang M; Qin C; Gao GF; Yan J
    Nat Microbiol; 2019 Jul; 4(7):1231-1241. PubMed ID: 30936489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Diversity of Rift Valley Fever Strains Circulating in Namibia in 2010 and 2011.
    Cosseddu GM; Magwedere K; Molini U; Pinoni C; Khaiseb S; Scacchia M; Marcacci M; Capobianco Dondona A; Valleriani F; Polci A; Monaco F
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33339456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Packaging of Rift Valley fever virus pseudoviruses and establishment of a neutralization assay method.
    Li Y; Zhao Y; Wang C; Zheng X; Wang H; Gai W; Jin H; Yan F; Qiu B; Gao Y; Li N; Yang S; Xia X
    J Vet Sci; 2018 Mar; 19(2):200-206. PubMed ID: 28693302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep.
    Morrill JC; Carpenter L; Taylor D; Ramsburg HH; Quance J; Peters CJ
    Vaccine; 1991 Jan; 9(1):35-41. PubMed ID: 2008798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-capture ELISA for the detection of Rift Valley fever virus nucleoprotein using new monoclonal antibodies.
    Fukushi S; Nakauchi M; Mizutani T; Saijo M; Kurane I; Morikawa S
    J Virol Methods; 2012 Mar; 180(1-2):68-74. PubMed ID: 22240075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious enveloped RNA virus antigenic chimeras.
    London SD; Schmaljohn AL; Dalrymple JM; Rice CM
    Proc Natl Acad Sci U S A; 1992 Jan; 89(1):207-11. PubMed ID: 1370348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.